Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.
2.

An Overview of Biomarkers and Molecular Signatures in HCC.

Yim SH, Chung YJ.

Cancers (Basel). 2010 May 7;2(2):809-23. doi: 10.3390/cancers2020809.

PMID:
24281095
[PubMed]
Free PMC Article
3.

Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Andreana L, Isgrò G, Pleguezuelo M, Germani G, Burroughs AK.

World J Hepatol. 2009 Oct 31;1(1):48-61. doi: 10.4254/wjh.v1.i1.48.

PMID:
21160965
[PubMed]
Free PMC Article
4.

IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.

White CD, Khurana H, Gnatenko DV, Li Z, Odze RD, Sacks DB, Schmidt VA.

BMC Gastroenterol. 2010 Oct 26;10:125. doi: 10.1186/1471-230X-10-125.

PMID:
20977743
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.

Röcken C, Licht J, Roessner A, Carl-McGrath S.

J Clin Pathol. 2005 Oct;58(10):1069-75.

PMID:
16189153
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis.

Thamboo TP, Wee A.

J Clin Pathol. 2004 Jan;57(1):48-53.

PMID:
14693835
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk